---
$id: https://graph.org.ai/products/commodity/51281818
$type: Product
source: UNSPSC
code: "51281818"
title: "Doxorubicin hydrochloride"
class: "51281800"
classTitle: "Anthracyclines"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Doxorubicin hydrochloride

**UNSPSC Code**: 51281818
**Class**: [Anthracyclines](Anthracyclines.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a doxorubicin preparation with the molecular formula C27H29NO11.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 82F2G7BL4E, chemically known as 3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-naphthacenyl 3-amino-2,3,6-trideoxyhexopyranoside but more generally known as doxorubicin hydrochloride, which bears US NIH Compound Identifier 1691. European Medicines Agency schedules Doxorubicin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01827MIG. Most nations, for tariff and trade purposes, schedule doxorubicin hydrochloride under HS 29419000 and SITC 54139. As of Q4 2014, DOXORUBICIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Doxorubicin hydrochloride bears US NLM identifiers UMLS ID C0085752 and NCI Concept Code C1326. SMILES: C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3C2C(C4C(C3O)C(=O)C5CCCC(C5C4=O)OC)O)(C(=O)CO)O)N)O.CL.

